Sichuan Kelun Pharmaceutical Hits Day High with Strong 5.89% Surge

Sichuan Kelun Pharmaceutical Co., Ltd. has experienced a notable increase of 5.89% on June 10, 2026, reaching an intraday high of CNY 37.20. This performance stands in contrast to the broader market, as the China Shanghai Composite index declined by 0.42% on the same day. Over the past week, Sichuan Kelun has shown a robust gain of 10.46%, while the composite index fell by 2.22%. In terms of longer-term performance, the stock has risen 26.27% year-to-date, significantly outperforming the composite index, which has only increased by 0.61%. However, over the past year, Sichuan Kelun has faced challenges, with a decline of 4.73%, while the composite index has gained 17.97%. The company operates within the pharmaceuticals and biotechnology sector and holds a market capitalization of CNY 39,696 million. Key financial metrics include a P/E ratio of 24.00 and a dividend yield of 3.62%. Despite recent gains, the company has reported negative results for the last six consecutive quarters, indicating ongoing financial pressures.